A detailed history of Voleon Capital Management LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Voleon Capital Management LP holds 149,041 shares of PLRX stock, worth $257,840. This represents 0.01% of its overall portfolio holdings.

Number of Shares
149,041
Holding current value
$257,840
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.18 - $1.86 $175,868 - $277,216
149,041 New
149,041 $221 Million
Q1 2025

May 15, 2025

BUY
$1.35 - $13.53 $97,236 - $974,525
72,027 New
72,027 $97.2 Million

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $84.2M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Voleon Capital Management LP Portfolio

Follow Voleon Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Voleon Capital Management LP with notifications on news.